Ironwood Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

• Ironwood Pharmaceuticals Inc IRWD.OQ reported quarterly adjusted earnings of 2 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of six analysts for the quarter was for earnings of 8 cents per share. Wall Street expected results to range from 3 cents to 16 cents per share.

• Revenue fell 23% to $90.55 million from a year ago; analysts expected $93.82 million.

• Ironwood Pharmaceuticals Inc's reported EPS for the quarter was 2 cents​.

• The company reported quarterly net income of $3.19 million.

• Ironwood Pharmaceuticals Inc shares had fallen by 61.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 49.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Ironwood Pharmaceuticals Inc is $7.50

This summary was machine generated from LSEG data February 27 at 04:57 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)